One of the most persistent questions on forums like r/SellMyBusiness and industry groups is some variation of: "What's my home care agency worth?" The honest answer is that valuation multiples vary dramatically based on agency size, and the gap between what a $1 million revenue agency sells for versus a $10 million agency is far wider than most owners realize. This article breaks down real transaction data by revenue tier so you can set realistic expectations for your specific situation. Plan your exit with our exit timeline calculator.
The Size Premium Is Real
Larger agencies command higher multiples, not just higher absolute values. A $10M revenue agency might sell for 7x EBITDA while a $1M agency sells for 3x. This isn't arbitrary. Larger agencies have more diversified revenue, deeper management teams, and lower integration risk for buyers. Understanding where you fall on this spectrum is the starting point for any exit conversation.
Why Size Drives Multiples
Before diving into the specific tiers, it's important to understand why larger agencies consistently command higher valuation multiples. The reasons are structural, not arbitrary, and understanding them helps you identify which factors you can actually influence before a sale.
Buyer pool expansion. A $1M revenue agency is typically only attractive to local competitors and individual buyers. A $5M agency attracts regional strategics and PE add-on buyers. A $10M+ agency attracts public strategics, PE platform builders, and national operators. More buyers means more competition, which drives higher multiples. According to Capstone Partners, public strategic buyers completed 20 transactions in 2025, but these were concentrated among larger, scaled operators.
Risk reduction. Smaller agencies tend to have higher owner dependency, less diversified payer mixes, and thinner management teams. These factors represent real risks for buyers. A $10M agency with a full management team, multiple payer contracts, and documented processes is simply a less risky acquisition than a $1M agency where the owner is the primary caregiver scheduler, marketer, and compliance officer.
Financing availability. Lenders are more willing to finance larger acquisitions, and the terms are typically more favorable. This means buyers can leverage more of the purchase price, which allows them to pay higher multiples while maintaining their return targets. For acquisitions under $2M, SBA lending is often the primary financing option, which comes with more restrictions and lower leverage ratios.
Synergy potential. Larger agencies offer more opportunities for the buyer to realize cost synergies (consolidating back-office functions, leveraging existing technology platforms) and revenue synergies (cross-selling services, expanding payer contracts). These synergies directly increase the value of the acquisition to the buyer, which they're willing to share with the seller through higher multiples.
Valuation by Revenue Tier
Tier 1: Under $1M Revenue (Micro Agencies)
| Metric | Typical Range |
|---|---|
| Valuation Method | SDE Multiple or Asset Sale |
| Typical Multiple | 1.5x – 3x SDE |
| Likely Buyers | Individual buyers, local competitors |
| Deal Structure | Often seller-financed, SBA loans |
Agencies under $1M in revenue are typically valued using Seller's Discretionary Earnings (SDE) rather than EBITDA, because the owner's compensation is such a large percentage of total expenses. At this size, the agency is essentially a job for the owner, and buyers are purchasing a book of business and a license rather than a scalable enterprise. The buyer pool is limited to individuals looking to purchase a job/business and local competitors looking to absorb patients and caregivers. Many transactions at this level are structured as asset sales rather than entity sales.
Tier 2: $1M – $3M Revenue (Small Agencies)
| Metric | Typical Range |
|---|---|
| Valuation Method | SDE or EBITDA Multiple |
| Typical Multiple | 2.5x – 4x SDE / 3x – 5x EBITDA |
| Likely Buyers | Local/regional competitors, PE add-ons |
| Deal Structure | Mix of cash at close + seller note or earnout |
This is where the market starts to get interesting. Agencies in the $1M-$3M revenue range are large enough to have some management infrastructure but typically still heavily dependent on the owner. The transition from SDE to EBITDA valuation usually happens in this range as agencies develop enough organizational structure to separate owner compensation from business earnings. PE-backed platforms may consider agencies at the upper end of this range as add-on acquisitions, particularly if the agency is in a strategic geographic market. The key to commanding the higher end of the multiple range at this size is demonstrating low owner dependency and a clear growth trajectory.
Tier 3: $3M – $5M Revenue (Mid-Size Agencies)
| Metric | Typical Range |
|---|---|
| Valuation Method | EBITDA Multiple |
| Typical Multiple | 4x – 6x EBITDA |
| Likely Buyers | Regional strategics, PE add-ons, some platforms |
| Deal Structure | Majority cash at close, possible earnout component |
The $3M-$5M range is a critical inflection point. Agencies at this size typically have enough revenue to support a small management team, multiple payer contracts, and some operational infrastructure. This is also the range where PE add-on interest becomes consistent. Transaction data from industry sources shows that agencies in the $4M-$9M revenue range have the most comparable transactions available for benchmarking. The key differentiators at this tier are payer mix diversification, margin consistency, and the quality of your clinical staff and management team.
Tier 4: $5M – $10M Revenue (Established Agencies)
| Metric | Typical Range |
|---|---|
| Valuation Method | EBITDA Multiple |
| Typical Multiple | 5x – 8x EBITDA |
| Likely Buyers | PE platforms, regional/national strategics |
| Deal Structure | Structured transaction, professional advisors on both sides |
Agencies in the $5M-$10M range attract serious institutional interest. These are large enough to serve as PE platform investments or meaningful strategic acquisitions. At this size, the due diligence process becomes more rigorous, often including a Quality of Earnings (QoE) analysis by a third-party accounting firm. Buyers at this level expect professional financial reporting, documented compliance programs, and a management team that can operate independently. The difference between a 5x and 8x multiple at this tier often comes down to growth trajectory, payer mix quality, and the strength of referral relationships.
Tier 5: $10M+ Revenue (Scaled Operators)
| Metric | Typical Range |
|---|---|
| Valuation Method | EBITDA Multiple (Enterprise Value) |
| Typical Multiple | 7x – 12x+ EBITDA |
| Likely Buyers | Public strategics, large PE firms, national operators |
| Deal Structure | Investment bank-led process, competitive auction |
At $10M+ in revenue, agencies enter the realm of institutional M&A. These transactions are typically managed by investment banks, involve multiple rounds of bidding, and attract the full spectrum of buyer types. Public company transaction data from Scope Research shows that public home health companies have traded at approximately 12.44x EBITDA, though private transactions typically close at a discount to public multiples. Multi-state operators with diversified service lines and strong value-based care capabilities command the highest premiums.
The Complete Picture: Revenue Tier Comparison
| Revenue Tier | Multiple Range | Buyer Pool Size | Key Value Driver |
|---|---|---|---|
| < $1M | 1.5x – 3x SDE | Very Limited | License value, patient census |
| $1M – $3M | 3x – 5x EBITDA | Limited | Growth trajectory, owner independence |
| $3M – $5M | 4x – 6x EBITDA | Moderate | Payer diversification, margin consistency |
| $5M – $10M | 5x – 8x EBITDA | Strong | Management team, compliance infrastructure |
| $10M+ | 7x – 12x+ EBITDA | Full Spectrum | Scale, VBC capabilities, market position |
How to Move Up in Multiple
While you can't change your agency's revenue tier overnight, you can influence the factors that determine where you fall within your tier's multiple range. The difference between the low and high end of each range often represents hundreds of thousands or millions of dollars in sale proceeds.
Clean your financials. Recast your P&L to show adjusted EBITDA with documented, defensible addbacks. Messy financials are the single most common reason agencies sell at the low end of their range. Start this process at least 12 months before going to market.
Diversify your payer mix. If more than 60% of your revenue comes from a single payer source, buyers will apply a concentration discount. Actively pursue new payer contracts, particularly Medicare Advantage and managed care, to demonstrate diversification.
Build your management team. Every dollar you invest in management depth before a sale can return 3x-5x through a higher multiple. A Director of Nursing, an office manager, and a scheduler who can operate without you are worth more than another $100K in revenue.
Document everything. Policies, procedures, training manuals, compliance programs. Buyers pay more for agencies where the knowledge lives in systems rather than in the owner's head. This is especially important for agencies in the $1M-$5M range where the gap between documented and undocumented operations is most stark.
Grow strategically. Revenue growth is valuable, but profitable revenue growth is what drives multiples. Adding $500K in revenue at 15% margins is more valuable than adding $1M at 5% margins. Focus on high-margin service lines and efficient operations rather than growth at any cost. For a comprehensive preparation roadmap, see our guide on how to prepare your agency for sale.
Frequently Asked Questions
Is revenue or EBITDA more important for valuation?
EBITDA is the primary valuation metric for agencies above $1M in revenue. However, revenue matters because it determines your buyer pool and the applicable multiple range. Two agencies with the same EBITDA but different revenues will often receive different multiples because the larger-revenue agency attracts more buyers and is perceived as less risky.
Do Medicare-certified agencies sell for more than non-medical agencies?
At the same revenue level, Medicare-certified home health agencies often command slightly higher multiples because the Medicare certification itself has value (it's a barrier to entry) and the revenue is more predictable. However, non-medical agencies with strong private-pay revenue and Medicaid waiver contracts can achieve comparable multiples, particularly if they have lower regulatory risk. See our detailed valuation multiples analysis for more on this comparison.
Can I increase my agency's value by growing revenue before selling?
Yes, but the math is nuanced. Growing from $2M to $3M in revenue might move you from a 3.5x to a 4x multiple, which means your valuation increases both from higher earnings and a higher multiple (the "double benefit"). However, growth that comes at the expense of margins or operational quality can actually reduce your multiple. The most effective strategy is to grow profitably while simultaneously improving the operational factors that drive multiples.